Trop molecules as targets for anti-tumor immunotherapy in man.
Alberti
S
S
Laboratory of Experimental Oncology, Department of Cell Biology and Oncology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy. alberti@cmns.mnegri.it
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000494:pharmacology*; D015815:Cell Adhesion Molecules; D000071858:Epithelial Cell Adhesion Molecule; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008562:Membrane Glycoproteins / Q000187:drug effects* / Q000276:immunology*; D009363:Neoplasm Proteins / Q000187:drug effects* / Q000276:immunology*; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D015815:Cell Adhesion Molecules; D000071858:Epithelial Cell Adhesion Molecule; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins